Michael Siah
Vascular Surgery · Dallas, TXNPI 1346668233
Payments from drug & device makers
Across 996 payments — averaging $841.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$157K
- Abbott$129K
- Shockwave Medical, Inc$107K
- Philips North America LLC$102K
- Stryker$98K
- Cagent Vascular Inc$71K
- plus $175K from 35 others
What the payments were for
- Consulting fees$174,38045%
- Speaking & faculty fees$89,53523%
- Grants$5,0001%
- Travel & lodging$73,93319%
- Food & beverage$48,90012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$102,563
- FLOWTRIEVER CATHETER, S$99,179
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$53,437
- Serrantor$40,864
- LIMFLOW SYSTEM$38,635
- (9520) IGT Devices Undivided$20,315
- Diamondback Peripheral$19,725
- ESPRIT$15,929
- IN.PACT Admiral$9,557
- Diamondback Coronary$5,601
- Endurant$5,000
- XIENCE SKYPOINT$3,850
- PERIPHERAL VASCULAR$2,609
- ZILVER 518$2,550
- XACT$2,125
- Omnilink Elite vascular stent system$1,700
- ENROUTE Transcarotid Neuroprotection System$1,591
- TurboHawk$1,079
- ENROUTE Transcarotid Stent System$862
- ENHANCE Transcarotid Peripheral Access Kit$862
How this compares
$838,433 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $16,024 |
| XareltoRivaroxaban | 24 | $14,680 |
| ClopidogrelClopidogrel Bisulfate | 27 | $322 |
| Oxycodone Hcl | 16 | $92 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Dallas
- Gregory PearlDallas$2.3M
- Stephen HohmannDallas$587K
- Dennis GableDallas$547K
- Carlos TimaranDallas$527K
- William ShutzeDallas$106K
- Bradley GrimsleyDallas$101K
- John KedoraDallas$101K
- John EidtDallas$100K
- Alton BurnsDallas$98K
- Javier VasquezDallas$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.